Javascript must be enabled to continue!
Predictors of statin adherence in primary care using real-world data
View through CrossRef
Abstract
Purpose
The objective of this study was to identify predictors of statin adherence in the primary and secondary prevention of CVD among patients in the first two years after the date of first prescription using real-world data.
Methods
The Electronic Practice Based Research Network Linked Dataset was used in this study. Statin adherence was calculated using a modified proportion of days covered (PDC) formula. Individuals with PDC ≥ 80% during the two years of observation period were considered as adherent. All analyses were performed with R software. Descriptive and multivariate logistic regression analyses were performed. Sensitivity analysis was performed using the Akaike Information Criterion model selection method.
Results
Overall, 3,432 patients accounting for 57,227 visits met the selection criteria. The mean PDC was 91.6% (±22.2%), and 72.0% of the patients were adherent to statins (PDC ≥ 80%) in the first two years after the date of first prescription. After adjusting for all other variables, statin adherence was positively associated with age (AOR 1.7, 95% CI 1.4 – 2.0), SEIFA index (AOR 1.8, 95% CI 1.2 – 2.6), polypharmacy (AOR 1.8, 95% CI 1.3 – 2.5) and comorbidities (AOR 1.4, 95% CI 1.1 – 1.7), and negatively associated with the number of statin types (AOR 0.6, 95% CI 0.5 – 0.9) and smoking status (AOR 0.7, 95% CI 0.6 – 0.9). The sensitivity analysis showed similar results as the regression model.
Conclusions
Statin adherence is influenced by an aging, multimorbid population, who are exposed to polypharmacy, multiple statin options and socioeconomic diversity.
Key points
Adherence in the first two years after the first date of statin prescription was measured as proportion of days covered (PDC)
The mean PDC was 91.6% (±22.2%)
72.0% of the patients were adherent to statins, with PDC ≥ 80%
Statin adherence was positively associated with age, area-based social advantage and disadvantage index, polypharmacy and comorbidities
Statin adherence was negatively associated with the number of statin types prescribed to the patients and the smoking status of patients
Plain Language Summary
The objective of this study was to identify predictors of statin adherence among patients in the first two years after the date of first prescription using real-world data. The dataset used was the Electronic Practice Based Research Network Linked Dataset. Statin adherence was calculated using proportion of days covered (PDC). A PDC ≥ 80% during the two years of observation period were considered as adherent. Overall, 3,432 patients were eligible for this study, and 72.0% of them were adherent to statins in the first two years after the date of first prescription. Statin adherence was positively associated with age, area-based social advantage and disadvantage index, number of medicines taken by the patient and number of chronic conditions that the patient suffered. Moreover, statin adherence was negatively associated with the number of statin types prescribed to the patients and smoking status of patients.
Title: Predictors of statin adherence in primary care using real-world data
Description:
Abstract
Purpose
The objective of this study was to identify predictors of statin adherence in the primary and secondary prevention of CVD among patients in the first two years after the date of first prescription using real-world data.
Methods
The Electronic Practice Based Research Network Linked Dataset was used in this study.
Statin adherence was calculated using a modified proportion of days covered (PDC) formula.
Individuals with PDC ≥ 80% during the two years of observation period were considered as adherent.
All analyses were performed with R software.
Descriptive and multivariate logistic regression analyses were performed.
Sensitivity analysis was performed using the Akaike Information Criterion model selection method.
Results
Overall, 3,432 patients accounting for 57,227 visits met the selection criteria.
The mean PDC was 91.
6% (±22.
2%), and 72.
0% of the patients were adherent to statins (PDC ≥ 80%) in the first two years after the date of first prescription.
After adjusting for all other variables, statin adherence was positively associated with age (AOR 1.
7, 95% CI 1.
4 – 2.
0), SEIFA index (AOR 1.
8, 95% CI 1.
2 – 2.
6), polypharmacy (AOR 1.
8, 95% CI 1.
3 – 2.
5) and comorbidities (AOR 1.
4, 95% CI 1.
1 – 1.
7), and negatively associated with the number of statin types (AOR 0.
6, 95% CI 0.
5 – 0.
9) and smoking status (AOR 0.
7, 95% CI 0.
6 – 0.
9).
The sensitivity analysis showed similar results as the regression model.
Conclusions
Statin adherence is influenced by an aging, multimorbid population, who are exposed to polypharmacy, multiple statin options and socioeconomic diversity.
Key points
Adherence in the first two years after the first date of statin prescription was measured as proportion of days covered (PDC)
The mean PDC was 91.
6% (±22.
2%)
72.
0% of the patients were adherent to statins, with PDC ≥ 80%
Statin adherence was positively associated with age, area-based social advantage and disadvantage index, polypharmacy and comorbidities
Statin adherence was negatively associated with the number of statin types prescribed to the patients and the smoking status of patients
Plain Language Summary
The objective of this study was to identify predictors of statin adherence among patients in the first two years after the date of first prescription using real-world data.
The dataset used was the Electronic Practice Based Research Network Linked Dataset.
Statin adherence was calculated using proportion of days covered (PDC).
A PDC ≥ 80% during the two years of observation period were considered as adherent.
Overall, 3,432 patients were eligible for this study, and 72.
0% of them were adherent to statins in the first two years after the date of first prescription.
Statin adherence was positively associated with age, area-based social advantage and disadvantage index, number of medicines taken by the patient and number of chronic conditions that the patient suffered.
Moreover, statin adherence was negatively associated with the number of statin types prescribed to the patients and smoking status of patients.
Related Results
GAMBARAN PROFIL LIPID PADA PASIEN PENYAKIT JANTUNG KORONER
GAMBARAN PROFIL LIPID PADA PASIEN PENYAKIT JANTUNG KORONER
Abstract: Coronary Heart Disease is a heart disease caused by the narrowing of the coronary arteries, which then disturbs the flow of blood to the myocardium. The result of SKRT do...
A Link Between Hypercholesterolemia and Chronic Lymphocytic Leukemia
A Link Between Hypercholesterolemia and Chronic Lymphocytic Leukemia
Abstract
Background
Dyslipidemia and metabolic syndrome are risk factors for cancer, and clinically aggressive CLL cells are believed to rely on lipid...
Abstract P1-15-03: Assessing the association of statins with clinical outcomes in women with breast cancer
Abstract P1-15-03: Assessing the association of statins with clinical outcomes in women with breast cancer
Abstract
Background: A growing number of studies are claiming lipid-lowering medications (LLMs) primarily statins have anticancer properties to inhibit proliferation...
1228-P: Comparison between Combination of Low- or Moderate-Intensity Statin with Ezetimibe and High-Intensity Statin Monotherapy for Primary Prevention of Cardiovascular Disease and All-Cause Mortalities in Patients with Type 2 Diabetes—A Propensity-Match
1228-P: Comparison between Combination of Low- or Moderate-Intensity Statin with Ezetimibe and High-Intensity Statin Monotherapy for Primary Prevention of Cardiovascular Disease and All-Cause Mortalities in Patients with Type 2 Diabetes—A Propensity-Match
Background and Aims: Here, we compared the effects of combination therapy of low- or moderate-statin with ezetimibe and high-intensity statin monotherapy in patients with type 2 di...
Statins Are Associated with Improved 28-day Mortality in Patients Hospitalized with SARS-CoV-2 Infection
Statins Are Associated with Improved 28-day Mortality in Patients Hospitalized with SARS-CoV-2 Infection
Abstract
Background
Statins may be protective in viral infection and have been proposed as treatment in severe acute respirator...
Fat-Free Mass and Fasting Glucose Values in Patients with and without Statin Therapy Assigned to Age Groups between <60 and >75 Years
Fat-Free Mass and Fasting Glucose Values in Patients with and without Statin Therapy Assigned to Age Groups between <60 and >75 Years
<b><i>Objective:</i></b> The aging-associated changes in body composition result in an increased cardiometabolic risk. A tremendous reduction of cardiovascu...
Abstract MP76: Trends in Adherence to Statin Therapy Among US Adults With Health Insurance Between 2007 and 2014
Abstract MP76: Trends in Adherence to Statin Therapy Among US Adults With Health Insurance Between 2007 and 2014
Background:
Statins are effective for the primary and secondary prevention of coronary heart disease (CHD) events. However, studies from the early 2000s have suggested ...
Woningcorporaties en Vastgoedontwikkeling
Woningcorporaties en Vastgoedontwikkeling
This summary highlights the findings of the PhD-thesis ‘Woningcorporaties en Vastgoedontwikkeling: Fit for Use’ (‘Housing associations and Real Estate Development: Fit for Use?’). ...

